Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00354965 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
NCT00354965 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 52 participants.
The verdict
NCT00354965, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
Clinical research study to test amoxicillin and clavulanate tablet formulation for use in Acute Bacterial Sinusitis (ABS) in adolescent patients weighing at least 40 kilogram (kg) and no more than 16 years old. ABS is an acute bacterial infection of the sinus. The purpose of this study is to find out how children tolerate Augmentin XR and what happens to Augmentin XR in the body after it has been swallowed by children.
Interventions
- DRUG amoxicillin/clavulanate potassium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2006-01-19 |
| Est. Completion | 2007-04-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00354965
The ClinicalTrials.gov registry entry for NCT00354965 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which amoxicillin/clavulanate potassium is the first listed.
NCT00354965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00354965 about?
NCT00354965 is a clinical study titled "Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients". Clinical research study to test amoxicillin and clavulanate tablet formulation for use in Acute Bacterial Sinusitis (ABS) in adolescent patients weighing at least 40 kilogram (kg) and no more than 16 years old. ABS is an acute bacterial infection of the sinus. The purpose of this study is to find ou...
What is the current status of trial NCT00354965?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2006-01-19. Estimated completion is 2007-04-02.
What interventions are being tested in trial NCT00354965?
The interventions under investigation include: amoxicillin/clavulanate potassium (DRUG).
Who is sponsoring clinical trial NCT00354965?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.